Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Biochemical Studies of Systemic Lupus Erythematosus-Associated Mutations in Nonreceptor Tyrosine Kinases Ack1 and Brk. | Biochemistry | 2023 | 36854171 | PubTator, text mining | PubMed |
| Exploring the molecular targets and mechanism of S. miltiorrhiza-C. aromatica in treating polycystic ovary syndrome based on network pharmacology. | Ann Transl Med | 2023 | 36846000 | PubTator, text mining | PubMed |
| Comparative Analysis of Dasatinib Effect between 2D and 3D Tumor Cell Cultures. | Pharmaceutics | 2023 | 36839692 | PubTator, text mining | PubMed |
| Novel Molecular Mechanisms Involved in the Medical Treatment of Pulmonary Arterial Hypertension. | Int J Mol Sci | 2023 | 36835558 | PubTator, text mining | PubMed |
| Multi-Omic Approaches to Classify, Predict, and Treat Acute Leukemias. | Cancers (Basel) | 2023 | 36831391 | PubTator, text mining | PubMed |
| Regulatory Role of Fatty Acid Metabolism-Related Long Noncoding RNA in Prostate Cancer: A Computational Biology Study Analysis. | J Oncol | 2023 | 36824662 | PubTator, text mining | PubMed |
| Identification of Gene Signature-Related Oxidative Stress for Predicting Prognosis of Colorectal Cancer. | Oxid Med Cell Longev | 2023 | 36819776 | PubTator, text mining | PubMed |
| Molecular and epigenetic alterations in normal and malignant myelopoiesis in human leukemia 60 (HL60) promyelocytic cell line model. | Front Cell Dev Biol | 2023 | 36819104 | PubTator, text mining | PubMed |
| Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine. | Mol Cell Proteomics | 2023 | 36805445 | PubTator, text mining | PubMed |
| Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy. | Gynecol Oncol | 2023 | 36804621 | PubTator, text mining | PubMed |
| Genetics of migraine: where are we now? | J Headache Pain | 2023 | 36800925 | PubTator, text mining | PubMed |
| Optimization of the Lead Compound NVP-BHG712 as a Colorectal Cancer Inhibitor. | Chemistry | 2023 | 36799129 | PubTator, text mining | PubMed |
| B-lymphoid tyrosine kinase-mediated FAM83A phosphorylation elevates pancreatic tumorigenesis through interacting with β-catenin. | Signal Transduct Target Ther | 2023 | 36797256 | PubTator, text mining | PubMed |
| Preclinical characterization of pirtobrutinib, a highly selective, noncovalent (reversible) BTK inhibitor. | Blood | 2023 | 36796019 | PubTator, text mining | PubMed |
| Noninvasive direct bilirubin detection by spectral analysis of color images using a Mini-LED light source. | Discov Nano | 2023 | 36795165 | PubTator, text mining | PubMed |
| Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy. | Sci Transl Med | 2023 | 36791206 | PubTator, text mining | PubMed |
| The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. | Clin Hypertens | 2023 | 36788612 | PubTator, text mining | PubMed |
| Primary maxillary sinus carcinosarcoma with multidisciplinary management: a case report with 4 years follow-up and literature review. | BMC Oral Health | 2023 | 36788533 | PubTator, text mining | PubMed |
| Neutron Reflectometry and Molecular Simulations Demonstrate HIV-1 Nef Homodimer Formation on Model Lipid Bilayers. | J Mol Biol | 2023 | 36773691 | PubTator, text mining | PubMed |
| Targeting Proliferation Signals and the Cell Cycle Machinery in Acute Leukemias: Novel Molecules on the Horizon. | Molecules | 2023 | 36770891 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=16